Works matching AU Gourdin, Theodore

Results: 9

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf138

By:

Beckermann, Kathryn E;
Shah, Neil J;
Campbell, Matthew T;
Haas, Naomi B;
Nelson, Ariel;
Ornstein, Moshe C;
Mao, Shifeng;
Keshava-Prasad, Holavanahalli S;
Hammers, Hans;
Gao, Xin;
Gourdin, Theodore;
George, Saby;
Hoimes, Christopher J;
Hussain, Arif;
Jonasch, Eric;
Rini, Brian I;
Voss, Martin H

Publication type:

Article

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 432, doi. 10.1093/oncolo/oyab075

By:

Jun, Tomi;
Hahn, Noah M;
Sonpavde, Guru;
Albany, Constantine;
MacVicar, Gary R;
Hauke, Ralph;
Fleming, Mark;
Gourdin, Theodore;
Jana, Bagi;
Oh, William K;
Taik, Patricia;
Wang, Huan;
Varadarajan, Ajay Ramakrishnan;
Uzilov, Andrew;
Galsky, Matthew D

Publication type:

Article

A phase I study of the ceramide nanoliposome in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 1, p. 23, doi. 10.1007/s00280-023-04588-7

By:

Ciner, Aaron;
Gourdin, Theodore;
Davidson, Jeff;
Parette, Mylisa;
Walker, Susan J.;
Fox, Todd E.;
Jiang, Yixing

Publication type:

Article

Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 7, p. 1533, doi. 10.3109/10428194.2013.856425

By:

Bhatnagar, Bhavana;
Duong, Vu H.;
Gourdin, Theodore S.;
Tidwell, Michael L.;
Chen, Ching;
Ning, Yi;
Emadi, Ashkan;
Sausville, Edward A.;
Baer, Maria R.

Publication type:

Article

Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials.

Published in:

Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 861, doi. 10.1177/1078155219875509

By:

McElwee, Jessica H;
Gourdin, Theodore S;
Mikoll, Jennifer;
Weeda, Erin;
Sion, Amy M

Publication type:

Article

Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.

Published in:

2019

By:

Sonpavde, Guru;
Agarwal, Neeraj;
Pond, Gregory Russell;
Nagy, Rebecca J.;
Nussenzveig, Roberto H.;
Hahn, Andrew W.;
Sartor, Oliver;
Gourdin, Theodore Stewart;
Nandagopal, Lakshminarayanan;
Ledet, Elisa M.;
Naik, Gurudatta;
Armstrong, Andrew J.;
Wang, Jue;
Bilen, Mehmet Asim;
Gupta, Shilpa;
Grivas, Petros;
Pal, Sumanta K.;
Lanman, Richard B.;
Talasaz, AmirAli;
Lilly, Michael B.

Publication type:

journal article

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.

Published in:

Asian Journal of Andrology, 2018, v. 20, n. 3, p. 1, doi. 10.4103/aja.aja_1_18

By:

Gourdin, Theodore;
Sonpavde, Guru

Publication type:

Article

Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer.

Published in:

Prostate, 2022, v. 82, n. 13, p. 1264, doi. 10.1002/pros.24400

By:

Bray, Alexander W.;
Duan, Rong;
Malalur, Pannaga;
Drusbosky, Leylah M.;
Gourdin, Theodore S.;
Hill, Elizabeth G.;
Lilly, Michael B.

Publication type:

Article

Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer.

Published in:

Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1202277

By:

Dincman, Toros A.;
Karam, Joseph A. Q.;
Giordano, Antonio;
Hong Li;
Drusbosky, Leylah M.;
Gourdin, Theodore S.;
Howe, Philip H.;
Lilly, Michael B.

Publication type:

Article